These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19760822)

  • 21. Qui tam: False Claims Act.
    Salcido R
    Adv Skin Wound Care; 2010 Nov; 23(11):487. PubMed ID: 20975328
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical activity to combat chronic diseases and escalating health care costs: the unfilled prescription.
    Franklin BA
    Curr Sports Med Rep; 2008; 7(3):122-5. PubMed ID: 18477867
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trial evidence and use of fish oil supplements.
    Grey A; Bolland M
    JAMA Intern Med; 2014 Mar; 174(3):460-2. PubMed ID: 24352849
    [No Abstract]   [Full Text] [Related]  

  • 25. On using the frontal lobe.
    Pontius JM
    J Okla State Med Assoc; 2009 Sep; 102(9):286. PubMed ID: 19894356
    [No Abstract]   [Full Text] [Related]  

  • 26. Fish-oil pills vs. claims.
    Consum Rep; 2012 Jan; 77(1):11. PubMed ID: 22232827
    [No Abstract]   [Full Text] [Related]  

  • 27. Pressure mounts for measures to control drug prices.
    Rice S
    Mod Healthc; 2015 Jul; 45(30):12. PubMed ID: 26510275
    [No Abstract]   [Full Text] [Related]  

  • 28. Fish-oil supplements slow atherosclerosis.
    Harv Heart Lett; 1999 Oct; 10(2):6. PubMed ID: 10534780
    [No Abstract]   [Full Text] [Related]  

  • 29. Bundle up.
    Bracken J
    Am J Nurs; 2009 Mar; 109(3):11. PubMed ID: 19240464
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription drug spending trends in the United States: looking beyond the turning point.
    Aitken M; Berndt ER; Cutler DM
    Health Aff (Millwood); 2009; 28(1):w151-60. PubMed ID: 19088102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pfizer breaks from merger mentality as others chase leads.
    Weaver J
    Nat Med; 2011 Jul; 17(7):761. PubMed ID: 21738140
    [No Abstract]   [Full Text] [Related]  

  • 32. 50 MOST INFLUENTIAL PHYSICIAN EXECUTIVES AND LEADERS 2016. The new drug regulator confronts major challenges.
    Johnson SR
    Mod Healthc; 2016 Apr; 46(14):14-8. PubMed ID: 27333705
    [No Abstract]   [Full Text] [Related]  

  • 33. Prescription drugs change healthcare spending patterns.
    Capitation Rates Data; 2007 May; 12(5):53-7. PubMed ID: 17506447
    [No Abstract]   [Full Text] [Related]  

  • 34. Buyer beware.
    Nature; 2010 Mar; 464(7288):465-6. PubMed ID: 20336086
    [No Abstract]   [Full Text] [Related]  

  • 35. We've got a health-cost crisis? Bunk!
    Reinhardt UW
    Med Econ; 1984 Jul; 61(15):28, 32, 34 passim. PubMed ID: 10310664
    [No Abstract]   [Full Text] [Related]  

  • 36. Ending the French love affair with drugs.
    Arie S
    BMJ; 2012 Oct; 345():e6996. PubMed ID: 23077372
    [No Abstract]   [Full Text] [Related]  

  • 37. ASCO, Others Design Tools To Measure the Worth of Drugs.
    Reinke T
    Manag Care; 2015 Dec; 24(12):21-2. PubMed ID: 26807469
    [No Abstract]   [Full Text] [Related]  

  • 38. The true cost and benefit of medication reduction.
    Aurigemma R
    Del Med J; 2009 Apr; 81(4):163-4. PubMed ID: 19552220
    [No Abstract]   [Full Text] [Related]  

  • 39. Captive markets.
    Mettner J
    Minn Med; 2008 Nov; 91(11):12-3. PubMed ID: 19108536
    [No Abstract]   [Full Text] [Related]  

  • 40. Health and economic consequences of counterfeit drugs.
    Seiter A
    Clin Pharmacol Ther; 2009 Jun; 85(6):576-8. PubMed ID: 19451909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.